Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research

Rona L Siskind1, Michele Andrasik, Shelly T Karuna

  • 1*Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; †Fred Hutchinson Cancer Research Center, HIV Vaccine Trials Network, Seattle, WA; ‡Microbicide Trials Network, Pittsburgh, PA; §Bridge HIV, San Francisco Department of Public Health, San Francisco, CA; ‖FHI360, HIV Prevention Trials Network, Durham, NC; and ¶University of Michigan School of Public Health, Ann Arbor, MI.

Summary

National Institutes of Health-funded HIV/AIDS networks are improving engagement with transgender (TG) individuals in research. Strategies include building partnerships, revising data collection, and enhancing cultural competency to improve TG health outcomes.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K